GlassScriptPhysician profile
Gregory Lifferth
NPI 1124552492
$7,100.91
in general payments reported to CMS, 2019-2025
23 companies · $417 in 2025
The $417 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $87.77 · 2021: $3,674 · 2022: $1,897 · 2023: $579 · 2024: $446 · 2025: $417.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,442.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,441.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alpha Orthopedic Systems | $3,668.20 | 2021-2022 | |
| Arthrex, INC. | $1,230.00 | 2021 | |
| Smith+Nephew, INC. | $439.29 | 2022 | |
| Elite Orthopedics, LLC | $278.25 | 2023-2025 | |
| Organogenesis INC. | $251.61 | 2021-2024 | Puraply |
| Abbvie INC. | $221.98 | 2021-2024 | |
| Paratek Pharmaceuticals, INC. | $175.93 | 2023-2025 | Nuzyra |
| Paragon 28, INC. | $159.14 | 2020-2025 | Monkey Rings, Ttc Nail |
| Bioventus LLC | $144.78 | 2022 | |
| Reprise Biomedical, INC. | $107.50 | 2023-2025 | Miro3d, Miroderm |
| Biowound Solutions, INC. | $61.53 | 2025 | Bio-Connekt |
| Solventum Corporation | $57.87 | 2024 | V.A.C. Veraflo, Activ.A.C., 3m Skin and Nasal Antiseptic |
| Acera Surgical, INC. | $55.21 | 2024 | Restrata Wound Matrix |
| Kerecis Limited | $46.67 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Averitas Pharma INC. | $41.40 | 2024-2025 | Qutenza |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Koya Medical, INC. | $36.67 | 2024 | Dayspring, Koya Medical |
| Treace Medical Concepts, INC. | $29.93 | 2024 | |
| Polynovo North America LLC | $21.00 | 2025 | Novosorb Btm |
| Melinta Therapeutics, LLC | $17.33 | 2022 | |
| Integra Lifesciences Corporation | $17.19 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Cashflow Solutions, LLC | $13.84 | 2023 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
| Kowa Pharmaceuticals America, INC. | $13.79 | 2023 | Seglentis |
| Allergan, INC. | $11.80 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Lifferth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.